Huma vs Pfizer
Side-by-side comparison of AI visibility scores, market position, and capabilities
Digital health platform with 50M+ patients engaged and 4,500+ hospital deployments; holds FDA 510k clearance for RPM; acquired Aluna (respiratory monitoring) in May 2025 and launched Pfizer hemophilia cloud platform in Jan 2025.
About
Huma (formerly Medopad) is a London-based digital health company that operates a cloud-based remote patient monitoring (RPM) and decentralized clinical trial platform used by hospitals, health systems, pharmaceutical companies, and medical device manufacturers. Founded in 2011, Huma has grown to serve more than 4,500 hospitals and clinics worldwide, engaging over 50 million patients through its digital health platform. The company's FDA Class II 510k-cleared RPM solution combines a patient-facing mobile app with a clinician portal that enables real-time monitoring of vital signs, symptoms, and treatment adherence, reducing unnecessary hospital admissions and enabling earlier clinical intervention.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
About
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.